Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. junior Avg
|
|
Filing tables
Filing exhibits
Related press release
STOK similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (No. 333-232191,No. 333-237345 and No. 333-254499) on Form S-8 and (No. 333-239801) on Form S-3, of our report dated March 10, 2022, with respect to the consolidated financial statements of Stoke Therapeutics, Inc.
/s/ KPMG LLP
Boston, Massachusetts
March 10, 2022